Core Viewpoint - The announcement from Henan Tailong Pharmaceutical Co., Ltd. indicates that over 5% shareholder Zhengzhou Zhongsheng Industrial Group Co., Ltd. has had its shares frozen and marked for judicial purposes, which may pose investment risks for stakeholders [2][3]. Group 1: Shareholder Information - Zhengzhou Zhongsheng holds 50,000,000 unrestricted tradable shares, all of which are currently pledged, representing 8.71% of the company's total share capital [2]. - As of the announcement date, all of Zhongsheng's shares (50,000,000) are frozen or marked for judicial purposes, accounting for 100% of its holdings [2][3]. Group 2: Legal and Financial Context - The shares were pledged in November 2016, and the judicial marking is due to financial loan contract disputes, with claims amounting to 35 million yuan and 284.51 million yuan respectively [3][4]. - The company clarifies that Zhongsheng is not the controlling shareholder, and this situation will not lead to a change in control of the company [3][5]. Group 3: Company Operations and Future Actions - The company will continue to monitor the situation and will fulfill its information disclosure obligations as necessary [5][6].
河南太龙药业股份有限公司关于持股5%以上股东股份被轮候冻结及司法标记的公告